SCHEMBL4499289

SCHEMBL4499289

CCOC(=O)Oc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3-n3cccc3C2CC)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
MMP8 P22894 3/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP14 P50281 1/20 0.40
ALDH1A1 P00352 3/20 0.38
POLB P06746 3/20 0.37
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
MMP3 P08254 1/20 0.36
NOD2 Q9HC29 1/20 0.36
NOD1 Q9Y239 1/20 0.36
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4488457 0.87 MMP8 (0.41) MEN1KMT2AMMP8MMP2MMP9
SCHEMBL4485706 0.85 MMP8 (0.40) MEN1KMT2AMMP8MMP2MMP9
SCHEMBL4496321 0.85 MMP8 (0.40) MEN1KMT2AMMP8MMP2MMP9
SCHEMBL4491386 0.85 MMP8 (0.40) MEN1KMT2AMMP8MMP2MMP9
SCHEMBL4511409 0.85 MMP8 (0.40) MEN1KMT2AMMP8MMP2MMP9
SCHEMBL4499956 0.85 MMP8 (0.40) MEN1KMT2AMMP8MMP2MMP9
SCHEMBL4496413 0.85 MMP8 (0.40) MEN1KMT2AMMP8MMP2MMP9
SCHEMBL4488144 0.85 PSEN1 (0.41) MEN1KMT2AMMP2ALDH1A1PSEN1
SCHEMBL4507460 0.84 MMP8 (0.39) MMP8MMP2MMP9MMP14ALDH1A1
SCHEMBL4490059 0.83 MMP8 (0.40) MEN1KMT2AMMP8MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7563793-B2 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents WYETH (US) 2009-07-21 US disclosed
US-20060160815-A1 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents WYETH (US) 2006-07-20 US disclosed
WO-2006068928-A1 PYRROLO[1,2-A]QUINOXALIN-5-(4H)-YL)SULFONYLS AND CARBONYLS AND THEIR USE AS ESTROGENIC AGENTS WYETH (US) 2006-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160815-A1 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents ESR1, GPER1, ESR2 MEN1 2574/4885KMT2A 860/4885MMP8 4531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.